NASDAQ : PIII
P3 Health Partners Inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 4.2 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 30.50M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 29.04M |
| Enterprise Value | 138.46M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 3.91M |
| Shares Outstanding | 7.26M |
| Shares Change (YoY) | +1.31% |
| Shares Change (QoQ) | -60.06% |
| Owned by Insiders (%) | 2.86% |
| Owned by Institutions (%) | 7.92% |
| Float | 2.29M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.02 |
| Forward PS | 0.04 |
| PB Ratio | 0.21 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.46 |
| Quick Ratio | 0.43 |
| Debt / Equity | 0.95 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.44 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -192.58% |
| Return on Assets (ROA) | -13.40% |
| Return on Invested Capital (ROIC) | -33.89% |
| Return on Capital Employed (ROCE) | -55.91% |
| Weighted Average Cost of Capital (WACC) | 32.52% |
| Revenue Per Employee | $4.70M |
| Profits Per Employee | -$337,528 |
| Employee Count | 320 |
| Asset Turnover | 2.17 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | -10.76M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.69 |
| 52-Week Price Change | -54.29% |
| 50-Day Moving Average | 6.61 |
| 200-Day Moving Average | 6.55 |
| Relative Strength Index (RSI) | 31.88 |
| Average Volume (20 Days) | 16,756 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 11,325 |
| Short Previous Month | 13,637 |
| Short % of Shares Out | 0.16% |
| Short % of Float | 0.49% |
| Short Ratio (days to cover) | 0.89 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.50B |
| Gross Profit | 70.59M |
| Operating Income | -148.63M |
| Pretax Income | -227.25M |
| Net Income | -108.01M |
| EBITDA | -64.48M |
| EBIT | -148.63M |
| Loss Per Share | -$32.73 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 21.27M |
| Total Debt | 130.69M |
| Net Cash | -109.42M |
| Net Cash Per Share | -$15.07 |
| Equity (Book Value) | 137.64M |
| Book Value Per Share | -23.59 |
| Working Capital | -209.24M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -130.52M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 84.15M |
| Net Borrowing | 54.96M |
| Free Cash Flow | -130.52M |
| FCF Per Share | -$17.98 |
Margins
| Measure | Value |
|---|
| Gross Margin | 4.70% |
| Operating Margin | -9.89% |
| Pretax Margin | -15.12% |
| Profit Margin | -6.55% |
| EBITDA Margin | -4.29% |
| EBIT Margin | -9.89% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.31% |
| Shareholder Yield | -1.31% |
| Earnings Yield | -818.34% |
| FCF Yield | -448.27% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $18.00 |
| Price Target Difference | 350.02% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 12.67% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Apr 14, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -0.19 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |